Equities
Health CareMedical Equipment and Services
  • Price (AUD)36.53
  • Today's Change-0.270 / -0.73%
  • Shares traded23.62k
  • 1 Year change+16.34%
  • Beta0.5902
Data delayed at least 20 minutes, as of Jul 18 2025 07:11 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, EBOS Group Ltd (EBO:ASX) closed at 36.53, -4.10% below its 52-week high of 38.09, set on Feb 11, 2025.
52-week range
Today
30.72Jul 18 202438.09Feb 11 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open36.79
High36.93
Low36.45
Bid35.78
Offer37.85
Previous close36.80
Average volume79.84k
Shares outstanding203.23m
Free float164.05m
P/E (TTM)28.83
Market cap8.18bn NZD
EPS (TTM)1.40
NZD
Annual div (ADY)1.17
AUD
Annual div yield (ADY)2.91%
Div ex-dateFeb 27 2025
Div pay-dateMar 21 2025
Data delayed at least 20 minutes, as of Jul 18 2025 07:11 BST.
More ▼

Events & Activity

  • EBO:ASX trading volume exceeds daily average by +260.39%
  • EBO:ASX price moved over -1.07% to 36.07
  • EBO:ASX price falls below 15-day moving average to 35.80 at 02:58 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.